Aakaar Medical Technologies MD, chairman, board of directors and AGM
NSE: AAKAARPersonal Products
Share price at the NSE close on 23 Oct 2026. Previous close ₹67.15.
- Next results date: the board meets on 30 Oct 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹90 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 17 Jun 2026
- 13.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 17 Jun 2026
- 1.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 17 Jun 2026
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 17 Jun 2026
- 0.34
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,200100.0% delivered
Aakaar Medical Technologies board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- C.B.Mehta & AssociatesPeer-review certificate valid to Jul 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Aakaar Medical Technologies AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Aakaar Medical Technologies share news and announcements
Annual general meeting, 30 Jun 2026
544 shareholders on the register on 29 May 2026; present: 5 promoters and 5 others; votes counted by DEVENDRA VASANT DESHPANDE / DVD & Associates.The company's voting result (opens in a new tab)
- Adoption of Financial StatementsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.27% · promoters 100.00% · institutions 10.06% · other public 18.74%
- Re-Appointment of Director Retiring by RotationOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.27% · promoters 100.00% · institutions 10.06% · other public 18.74%
- Approval for Employee Stock Option.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.27% · promoters 100.00% · institutions 10.06% · other public 18.74%
- INCREASE IN AUTHORISED SHARE CAPITAL AND CONSEQUENT ALTERATION TO CAPITAL CLAUSE OF MEMORANDUM OF ASSOCIATION.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.27% · promoters 100.00% · institutions 10.06% · other public 18.74%
- APPOINTMENT OF SECRETARIAL AUDITOR.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.27% · promoters 100.00% · institutions 10.06% · other public 18.74%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Mar 2026.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Public IssuesJun 2025 | 27.00 | Working Capital Requirement | 20.35 | 9.35 | No |
| Public IssuesJun 2025 | 27.00 | General Corporate Purpose | 3.29 | 0.01 | No |
| Public IssuesJun 2025 | 27.00 | Issue Expenses with GST | 3.36 | 3.36 | No |